Why the study?
Does a modified position management protocol incorporating dynamic postural adjustments and breathing exercises improve oxygenation parameters, dyspnea, comfort, and quality of life compared to conventional postural care in hospitalized patients with heart-failure-associated dyspnea?
Does a modified position management protocol incorporating dynamic postural adjustments and breathing exercises improve oxygenation parameters, dyspnea, comfort, and quality of life compared to conventional postural care in hospitalized patients with heart-failure-associated dyspnea?
In hospitalized patients with heart failure and resting dyspnea, an individualized 1-week dynamic positioning and breathing protocol significantly improves arterial oxygenation, relieves dyspnea, and enhances patient comfort and short-term quality of life compared to standard static positioning.
Answers are grounded in this paper and cite their sources.
May support modified positioning in HF dyspnea care; extends randomized evidence for non-pharmacological strategies but requires multicenter validation.
Aims To test whether a modified position‐management protocol improves oxygenation, dyspnea, and quality of life in heart‐failure‐associated dyspnea in a tertiary hospital in China. Methods and Results This single‐center, parallel‐group, randomized, superiority trial enrolled 150 patients hospitalized at Union Hospital, Tongji Medical College, Huazhong University of Science and Technology from January to December 2023 who met the inclusion criteria (age ≥ 18 years, chronic heart failure per 2021 ESC guidelines, dyspnea with mMRC ≥ 2 or Borg ≥ 3 at rest) and without exclusion criteria (e.g., severe underlying pulmonary diseases, severe cardiac comorbidities, cognitive disorders). Patients were randomized into a control group (conventional postural care) and an intervention group (modified position management). The allocation sequence was generated using SAS 9.4 with a block size of 4 and concealed in opaque envelopes by an independent statistician. Over 1 week, oxygenation parameters (PaO 2 , SaO 2 , PaO 2 /FiO 2 ), dyspnea severity (Modified Borg Scale, MBS), and comfort levels (Kolcaba General Comfort Questionnaire, GCQ) were assessed. Quality of life was evaluated using the Short Form Health Survey (SF‐36). Outcome assessors were blinded to group allocation. The primary endpoint was analyzed by ANCOVA, adjusting for baseline value. All 150 participants (75 per group) completed the intervention and were included in the final analysis. After 1 week, the intervention group showed significantly higher PaO 2 (82.49 ± 7.81 vs. 76.55 ± 7.11 mmHg; mean difference 5.94 mmHg [95% CI 3.49 to 8.39]), SaO 2 (90.33 ± 4.69 vs. 84.15 ± 6.95%; mean difference 6.18% [95% CI 4.23 to 8.13]), and PaO 2 /FiO 2 (288.50 ± 26.85 vs. 243.40 ± 25.30; mean difference 45.10 [95% CI 36.35 to 53.85]) compared to control (all p < 0.001). MBS scores were significantly lower in the intervention group (3 [3, 5] vs. 5 [3, 7], p < 0.001). GCQ scores were significantly higher (98.24 ± 4.19 vs. 85.17 ± 4.47, p < 0.001). Spearman's correlation revealed strong negative correlations between dyspnea and comfort scores ( r = −0.6362, p < 0.0001). SF‐36 scores across all dimensions were higher in the intervention group ( p < 0.05). No intervention‐related adverse events were reported. Conclusion Modified position management effectively improves oxygenation, reduces dyspnea, enhances comfort, and significantly boosts quality of life in heart failure patients with dyspnea. Trial Registration: Not applicable. This trial was not prospectively registered in a public clinical trial registry, which is a major limitation of the study and is explicitly acknowledged in the Limitations section.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: